Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: A randomised placebo controlled double blind 52 weeks clinical trial

Annals of the Rheumatic Diseases

Volumn 55, Issue 10, 1996, Pages 739-744

  Peeters, H R M ^a   Jongen Lavrencic, M ^a   Vreugdenhil, G ^b   Swaak, A J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ST JOSEPH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; PLACEBO; PREDNISONE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029851857     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.10.739     Document Type: Article

References (44)

1. Mowat AG. Hematologic abnormalities in rheumatoid arthritis. Semin Arthitis Rheum 1971;1:383-90.
2. Hansen NE. The anaemia of chronic disorders: a bag of unsolved questions. Scand J Haematol 1983;31:397-402.
3. Vreugdenhil G, Wognum AW, Van Eijk HG, Swaak AJ. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis 1990;49:93-8.
4. Peeters HRM, Jongen-Lavrencic M, Raja AN, Ramdin HS, Vreugdenhil G, Breedveld FC, et al. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis 1996;55:162-8.
5. Cartwright GE, Lee GR. The anaemia of chronic disorders. Br J Haematol 1971;21:147-52.
6. Krantz SB. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci 1994;307:353-9.
7. Smith RJ, Davis P, Thomson ABR, Wadsworth LD, Fackre P. Serum ferritin levels in the anaemia of rheumatoid arthritis. J Rheumatol 1977;4:389-92.
8. Roester HP. Iron metabolism in inflammation and malignant disease. In: Jacobs A, Worwood M, eds. Iron in biochemistry and medicine II. London: Academic Press, 1980:605-40.
9. Maury CJP, Anderson LC, Teppo AM, Partanen S, Juvonen E. Mechanism of the anaemia in rheumatoid arthritis: demonstration of raised interleukin 1beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukemia (HEL). Ann Rheum Dis 1988; 47:972-87.
10. Roodman GD, Bird A, Hutzer D, Montgomery W. Tumor necrosis factor-alpha and haematopoietic progenitors CFU-E and BFU-E and the haematopoietic cell lines K562, HL60 and HEL cells. Exp Hematol 1987;15:928-35.
11. Means RT, Krantz SB. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin [see comments]. Blood 1991;78:2564-7.
12. Jongen-Lavrencic M, Peeters HRM, Wognum AW, Vreugdenhil G, Swaak AJG. Erythropoietin receptor expression on bone marrow cells from rheumatoid arthritis patients with anaemia of chronic disease and control patients. Clin Rheumatol 1994;13:176.
13. Baer AN, Dessypries EN, Goldwasser E, Krantz SB. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987;66:559-64.
14. Hochberg MC, Arnold CM, Hogans BB, Spivak JL. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum 1988; 31:1318-21.
15. Vreugdenhil G, Kontoghiorghes GJ, Van Eijk HG, Swaak AJG. Impaired erythropoietin responsivenes to the anemia in rheumatoid arthritis. A possible inverse relationship with iron stores and effects of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Clin Exp Rheumatol 1991;9:35-40.
16. Jelkman W, Pagel H, Wolff M, Fandrey J. Monokines inhibit erythropoietin production in human hepatoma cultures and isolated perfused rat kidneys. Life Sci 1991;50:301-8.
17. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992;79:1987-94.
18. Means RT, Olsen NJ, Krantz ST, Dessypris EN, Graber SE, Stone WJ, et al. Treatment of the anemia of rheumatoid arthritis with recombinant erythropoietin:clinical and in vivo studies. Arthritis Rheum 1989;32:638-42.
19. Takashina N, Kondo H, Kashiwazaki S. Suppressed serum erythropoietin response to anaemia and the efficacy of recombinant erythropoietin in the anaemia of rheumatoid arthritis. J Rheumatol 1990;17:885-7.
20. Pincus T, Olsen NJ, Russel J, Wolfe F, Harris ER, Boccagno JA, et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990;89:161-8.
21. Salvarani C, Lasagni D, Casali B, Macchioni P, Boiardi L, Rossi F, et al. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease. J Rheumatol 1991;18:1168-71.
22. Güdbjörnsson B, Hällgren R, Wide L, Birgegård G. Response of anaemia in rheumatoid erthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis 1992;51:747-52.
23. Pettersson T, Rosenlöf K, Friman C, Mickos A, Teppo A-M, Fyhrquist F. Succesful treatment of the anaemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropietin. .Scand J Rheumatol 1993;22:188-93.
24. Murphy EA, Bell AL, Wojtulewski J, Brzeski M, Madhok R, Capell HA. Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis. BMJ 1994; 309:1337-8.
25. Vreugdenhil G, Manger B, Nieuwenhuizen C, Feelders RA, Van Eijk HG, Swaak AJG. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis. Ann Hematol 1992;65:265-8.
26. Eschbach JW. Erythropoietin 1991 - an overview. Am J Kidney Dis 1991;18(suppl 1):3-9.
27. Swaak AJG, Nieuwenhuizen C, Vreugdenhil G. Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD). Clin Exp Rheumatol 1995;12:577.
28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
29. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The Americam College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35:498-502.
30. Lundin P, Persson E, Weinfeld A. Comparison of hemosiderin estimation in bone marrow sections and bone marrow smears. Acta Med Scand 1964;175:383-90.
31. Paulus HE, Egger MJ, Ward JR, Williams HJ. Cooperative systemic studies of rheumatic diseases group. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990;33:477-84.
32. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36:729-40.
33. McConkey B. Clinical conundrum. Br J Rheumatol 1990;29:88.
34. Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol 1984;13:39-44.
35. Kirwan JR. The Arthritis and Rheumatism Council Low-dose Glucorticoid Study Group. The effect of glucocorticosteroids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
36. Kooistra MP, van Es A, Struyvenberg A, Marx JJM. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. Br J Haematol 1991;79:634-9.
37. Muirden KD, Senator GB. Iron in the synovial membrane in rheumatoid arthritis and other joint diseases. Ann Rheum Dis 1968;27:38-48.
38. Biemond P, Swaak AJG, Van Eijk HG, Koster JF. Intraarticular ferritin-bound iron in rheumatoid arthritis. Arthritis Rheum 1986;29:1187-93.
39. Blake DR, Gallagher PJ, Potter AR, Bell MJ, Bacon PA. The effect of synovial iron on the progression of rheumatoid disease. Arthritis Rheum 1984;27:495-501.
40. Nishiya K. Stimulation of human synovial cell DNA synthesis by iron. J Rheumatol 1994;21:1802-7.
41. Reddy PS, Lewis M. The adverse effects of intravenous iron dextran in rheumatoid arthritis. Arthritis Rheum 1969; 12:454-7.
42. Magaro M, Zoli A, Altomonte L, Mirone L, Corvino G, Storti S. Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation. Ann Rheum Dis 1990;49:268-9.
43. Kimata H, Yoshida A, Ishioka C, Mikawa H. Effect of recombinant human erythropoietin on human IgE production in vitro. Clin Exp Immunol 1991;83:483-7.
44. Singh AB, Singh M, Palekar S, Levy S, Nunn C, Mann RA. The effects of recombinant human erythropoietin on the cell mediated immune response of renal failure patients. J Med Clin Exp Theoret 1992;23:289-302.